IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v44y1998i3p253-260.html
   My bibliography  Save this article

What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?

Author

Listed:
  • Schneeweiss, Sebastian
  • Schoffski, Oliver
  • Selke, Gisbert W

Abstract

No abstract is available for this item.

Suggested Citation

  • Schneeweiss, Sebastian & Schoffski, Oliver & Selke, Gisbert W, 1998. "What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?," Health Policy, Elsevier, vol. 44(3), pages 253-260, June.
    • Handle: RePEc:eee:hepoli:v:44:y:1998:i:3:p:253-260
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(98)00023-2
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Anonymous, 1990. "Editor's Report, 1990," Journal of Agricultural and Applied Economics, Cambridge University Press, vol. 22(1), pages 221-223, July.
    2. Ljungkvist, Mats-Olof & Andersson, David & Gunnarsson, Bo, 1997. "Cost and utilisation of pharmaceuticals in Sweden," Health Policy, Elsevier, vol. 41(Supplemen), pages 55-69, September.
    3. von der Schulenburg, J. -Matthias Graf, 1997. "Management of cost and utilization of pharmaceuticals in Germany," Health Policy, Elsevier, vol. 41(Supplemen), pages 45-53, September.
    4. Abel-Smith, Brian & Mossialos, Elias, 1994. "Cost containment and health care reform: a study of the European Union," Health Policy, Elsevier, vol. 28(2), pages 89-132, May.
    5. Kane, Nancy M. & Saltman, Richard B., 1997. "Comparative experience in home care and pharmaceutical policy," Health Policy, Elsevier, vol. 41(Supplemen), pages 1-7, September.
    6. Kane, Nancy M., 1997. "Pharmaceutical cost containment and innovation in the United States," Health Policy, Elsevier, vol. 41(Supplemen), pages 71-89, September.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Lopez-Casasnovas, Guillem & Puig-Junoy, Jaume, 2000. "Review of the literature on reference pricing," Health Policy, Elsevier, vol. 54(2), pages 87-123, November.
    2. Bergstrom, Gina & Karlberg, Ingvar, 2007. "Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden: Assessment of models for decentralized financing of subsidies from a management perspective," Health Policy, Elsevier, vol. 81(2-3), pages 358-367, May.
    3. Busse, Reinhard, 1999. "Priority-setting and rationing in German health care," Health Policy, Elsevier, vol. 50(1-2), pages 71-90, December.
    4. Schneeweiss, Sebastian & Maclure, Malcolm & Walker, Alexander M. & Grootendorst, Paul & Soumerai, Stephen B., 2001. "On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective," Health Policy, Elsevier, vol. 55(2), pages 97-109, February.
    5. Fabiano, Valentina & Mameli, Chiara & Cattaneo, Dario & Delle Fave, Antonella & Preziosa, Alessandra & Mele, Giuseppe & Clementi, Emilio & Zuccotti, Gian Vincenzo, 2012. "Perceptions and patterns of use of generic drugs among Italian Family Pediatricians: First round results of a web survey," Health Policy, Elsevier, vol. 104(3), pages 247-252.
    6. Andersson, Karolina & Bergstrom, Gina & Petzold, Max G. & Carlsten, Anders, 2007. "Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals," Health Policy, Elsevier, vol. 81(2-3), pages 376-384, May.
    7. Andersson, Karolina & Petzold, Max Gustav & Sonesson, Christian & Lonnroth, Knut & Carlsten, Anders, 2006. "Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?: Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002," Health Policy, Elsevier, vol. 79(2-3), pages 231-243, December.
    8. Schneeweiss, Sebastian, 2007. "Reference drug programs: Effectiveness and policy implications," Health Policy, Elsevier, vol. 81(1), pages 17-28, April.
    9. Garattini, Livio & Tediosi, Fabrizio, 2000. "A comparative analysis of generics markets in five European countries," Health Policy, Elsevier, vol. 51(3), pages 149-162, April.
    10. Schreyögg, Jonas & Henke, Klaus-Dirk & Busse, Reinhard, 2004. "Managing pharmaceutical regulation in Germany: Overview and economic assessment," Discussion Papers 2004/6, Technische Universität Berlin, School of Economics and Management.
    11. Hokkanen, Joni & Kangasharju, Aki & Linnosmaa, Ismo & Valtonen, Hannu, 2012. "Generic substitution policy, prices and market structure: evidence from a quasi-experiment in Finland," Working Papers 35, VATT Institute for Economic Research.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Bergstrom, Gina & Karlberg, Ingvar, 2007. "Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden: Assessment of models for decentralized financing of subsidies from a management perspective," Health Policy, Elsevier, vol. 81(2-3), pages 358-367, May.
    2. Eulàlia Dalmau & Jaume Puig, 1997. "Market structure and hospital efficiency: Evaluating potential effects of deregulation in a national health service," Economics Working Papers 214, Department of Economics and Business, Universitat Pompeu Fabra.
    3. Adriana Benítez-Rico & Arizbeth Pérez-Martínez & Bryan Isaac Muñóz-López & Laura Martino-Roaro & Jorge Adan Alegría-Baños & Arely Vergara-Castañeda & Alejandro Islas-García, 2023. "Medical Household Waste as a Potential Environmental Hazard: An Ecological and Epidemiological Approach," IJERPH, MDPI, vol. 20(7), pages 1-18, April.
    4. Aletras, Vassilios & Kontodimopoulos, Nick & Zagouldoudis, Athanasios & Niakas, Dimitris, 2007. "The short-term effect on technical and scale efficiency of establishing regional health systems and general management in Greek NHS hospitals," Health Policy, Elsevier, vol. 83(2-3), pages 236-245, October.
    5. Gevers, J.M.P. & Gelissen, J.P.T.M. & Arts, W.A. & Muffels, R.J.A., 1999. "Public health care in balance : Exploring popular support for health care systems in the European Union," WORC Paper 99.12.04, Tilburg University, Work and Organization Research Centre.
    6. Maurizio Pugno & Francesco Sarracino, 2021. "Structural Changes in Economic Growth and Well-Being: The Case of Italy’s Parabola," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 158(3), pages 801-838, December.
    7. Sarracino, Francesco & O'Connor, Kelsey J. & Ono, Hiroshi, 2019. "Making economic growth and well-being compatible: evidence from Japan," MPRA Paper 93010, University Library of Munich, Germany.
    8. Liaropoulos, Lycurgus L., 1995. "Health services financing in Greece: a role for private health insurance," Health Policy, Elsevier, vol. 34(1), pages 53-62, October.
    9. Borras, Josep M. & Granados, Alicia & Escarrabill, Joan & de Lissovoy, Gregory, 1996. "Complex decisions about an uncomplicated therapy: reimbursement for long-term oxygen therapy in Catalonia (Spain)," Health Policy, Elsevier, vol. 35(1), pages 53-59, January.
    10. Martin Kenneally & Brenda Lynch, 2018. "Ageing, health status and coverage rate effects on community prescription costs in Ireland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(5), pages 687-695, June.
    11. Hutchinson, James M & Lo, Andrew W & Poggio, Tomaso, 1994. "A Nonparametric Approach to Pricing and Hedging Derivative Securities via Learning Networks," Journal of Finance, American Finance Association, vol. 49(3), pages 851-889, July.
    12. Merve Suzan ILIK BİLBEN, 2018. "Antropojenik İklim Değişikliği Bağlamında Göç Tartışmaları," Journal of Social Policy Conferences, Istanbul University, Faculty of Economics, vol. 0(75), pages 237-268, December.
    13. Blazej Lyszczarz, 2016. "The effect of health care model on health systems' responses to economic crises," Ekonomia i Prawo, Uniwersytet Mikolaja Kopernika, vol. 15(4), pages 493-501, December.
    14. Matthieu Crozet & Laura Hering & Sandra Poncet, 2018. "Looking for the Bright Side of the China Syndrome: Rising Export Opportunities and Life Satisfaction in China," Working Papers 2018-14, CEPII research center.
    15. Lewis A K Barnett & Megan V Winton & Shaara M Ainsley & Gregor M Cailliet & David A Ebert, 2013. "Comparative Demography of Skates: Life-History Correlates of Productivity and Implications for Management," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-13, May.
    16. Götze, Ralf & Schmid, Achim, 2012. "Healthcare financing in OECD countries beyond the public-private split," TranState Working Papers 160, University of Bremen, Collaborative Research Center 597: Transformations of the State.
    17. Donald Vandegrift & Anusua Datta, 2006. "Prescription Drug Expenditures in the United States: The Effects of Obesity, Demographics, and New Pharmaceutical Products," Southern Economic Journal, John Wiley & Sons, vol. 73(2), pages 515-529, October.
    18. Prosser, Helen & Walley, Tom, 2005. "A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing," Social Science & Medicine, Elsevier, vol. 60(6), pages 1335-1346, March.
    19. Ravi Kanbur, 2004. "Growth, Inequality And Poverty: Some Hard Questions," Working Papers 157, Institute for Social and Economic Change, Bangalore.
    20. repec:jtr:journl:v:9:y:2014:i:1:p:159-173 is not listed on IDEAS
    21. Francesco Sarracino & Kelsey J. O’Connor, 2021. "Economic growth and well-being beyond the Easterlin paradox," Chapters, in: Luigino Bruni & Alessandra Smerilli & Dalila De Rosa (ed.), A Modern Guide to the Economics of Happiness, chapter 9, pages 162-188, Edward Elgar Publishing.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:44:y:1998:i:3:p:253-260. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.